11/02/2026 - Conferences, Projects, Research

IGTP coordinates European project TB-SPECTRUM to advance understanding of the tuberculosis disease spectrum

IGTP has launched the European project TB-SPECTRUM, funded under the Horizon Europe programme through the MSCA Staff Exchanges scheme and coordinated by IGTP. A kick-off meeting held online brought together researchers, clinicians, and representatives from academic and non-academic institutions across Europe, Africa, and the United States, alongside members of the project's External Scientific and Ethics Advisory Boards.

09/02/2026 - Research

A study links the protein HDAC11 as a key factor in muscle deterioration in Duchenne muscular dystrophy

A preclinical study led by IGTP, in collaboration with the Institut de Myologie and the IR Sant Pau, has analysed the role of the protein HDAC11 in Duchenne muscular dystrophy and its potential as a therapeutic target. The results of the study have been published in the journal Life Sciences.

04/02/2026 - Campus Can Ruti, Research

Large-scale study analyses the impact of climate on Legionnaires’ disease in Catalonia

A multidisciplinary work led by IGTP researchers has analysed the relationship between climatic conditions, the presence of Legionella in water systems and cases of Legionnaires' disease in Catalonia, revealing a link between these different factors.

30/01/2026 - Research

A systematic review organises available omics data on pituitary tumours

A recent study has carried out a systematic review of the scientific literature on omics data generated in pituitary tumours, with the aim of organising, cataloguing and facilitating the reuse of publicly available resources for future research projects.

28/01/2026 - Research

Study identifies PARG as a new target to enhance chemotherapy in colorectal cancer

A study led by researchers from the Resistance, Chemotherapy and Predictive Biomarkers group at the IGTP, published in Clinical and Translational Medicine, provides new evidence on how to improve the efficacy of one of the most widely used chemotherapy combinations in clinical practice for the treatment of colorectal cancer: 5-fluorouracil and irinotecan (FUIRI).

31/12/2025 - Campus Can Ruti, Innovation, Institutional, Outreach, Research, Success Stories

IGTP in 2025: 12 selected news stories

We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.

23/12/2025 - Campus Can Ruti, Research

Germans Trias Hospital launches the first screening program in Catalonia to detect type 1 diabetes before the onset of symptoms

Early diagnosis can help prevent serious complications, reduce hospital admissions and minimise the impact of disease onset in children and adolescents

22/12/2025 - Campus Can Ruti, Research

A new study explores why the same mutation in the BRAF gene leads to different therapeutic responses to its inhibitors in melanoma and colorectal cancer

Researchers from the B·ARGO at IGTP and ICO have conducted a comparative analysis of the impact of BRAF gene mutations in melanoma and colorectal cancer, published in the journal BBA Reviews on Cancer.

17/12/2025 - Research

The antibiotic delafloxacin emerges as a potential therapeutic alternative against Legionella

A study led by IGTP researchers shows that, in a laboratory model, delafloxacin inhibits the intracellular replication of Legionella more effectively than a current standard treatment, supporting its potential therapeutic value and the need for future clinical studies.

16/12/2025 - Research

Occupational factors strongly influence Long-COVID risk

Work-related factors play a significant and independent role in the risk of developing Long-COVID, shows a new study based on the COVICAT cohort and led by ISGlobal, in collaboration with the University of Turin and the IGTP. The findings, published in BMJ Occupational & Environmental Medicine, highlight that a substantial share of Long-COVID could be prevented through targeted workplace measures and policies.